Results of a Phase II trial with weekly administration of TCF and concurrent radiotherapy
Neoadjuvant therapy with weekly docetaxel and cisplatin, 5-fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long-lasting pathological complete response: A phase 2 study.
PASINI, Felice;DE MANZONI, Giovanni;CORDIANO, Claudio
AbstractResults of a Phase II trial with weekly administration of TCF and concurrent radiotherapy
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.